Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pituitary Abscess: A Challenging Preoperative Diagnosis-A Multicenter Study.
Mallereau CH, Todeschi J, Ganau M, Cebula H, Bozzi MT, Romano A, Le Van T, Ollivier I, Zaed I, Spatola G, Nannavecchia B, Mahoudeau P, Djennaoui I, Debry C, Signorelli F, Ligarotti GKI, Pop R, Baloglu S, Fasciglione E, Goichot B, Bund C, Gaudias J, Proust F, Chibbaro S. Mallereau CH, et al. Among authors: goichot b. Medicina (Kaunas). 2023 Mar 14;59(3):565. doi: 10.3390/medicina59030565. Medicina (Kaunas). 2023. PMID: 36984566 Free PMC article.
Is the OCT a predictive tool to assess visual impairment in optic chiasm compressing syndrome in pituitary macroadenoma? A prospective longitudinal study.
Bozzi MT, Mallereau CH, Todeschi J, Baloglu S, Ardellier FD, Romann J, Trouve L, Bocsksei Z, Alcazar J, Dannhoff G, Bahougne T, Goichot B, Chibbaro S, Cebula H. Bozzi MT, et al. Among authors: goichot b. Neurosurg Rev. 2024 Jan 17;47(1):50. doi: 10.1007/s10143-024-02280-9. Neurosurg Rev. 2024. PMID: 38228894
[68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation.
Pepponi M, Berti V, Fasciglione E, Montanini F, Canu L, Hubele F, Abenavoli E, Briganti V, Rapizzi E, Charpiot A, Taieb D, Pacak K, Goichot B, Imperiale A. Pepponi M, et al. Among authors: goichot b. Eur J Nucl Med Mol Imaging. 2024 Apr 30. doi: 10.1007/s00259-024-06735-5. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38687372
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
Lin AL, Rudneva VA, Richards AL, Zhang Y, Woo HJ, Cohen M, Tisnado J, Majd N, Wardlaw SL, Page-Wilson G, Sengupta S, Chow F, Goichot B, Ozer BH, Dietrich J, Nachtigall L, Desai A, Alano T, Ogilive S, Solit DB, Bale TA, Rosenblum M, Donoghue MTA, Geer EB, Tabar V. Lin AL, et al. Among authors: goichot b. Acta Neuropathol. 2024 May 17;147(1):85. doi: 10.1007/s00401-024-02736-8. Acta Neuropathol. 2024. PMID: 38758238 Free PMC article.
Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study.
Mekkan-Bouv Hez M, Derbey L, de Mestier L, D L, Walter T, Perrier M, Cadiot G, Goichot B, Pracht M, Lièvre A, Coriat R, Valancot S, Guimbaud R, Carrere N, Bacoeur-Ouzillou O, Belleannée G, Smith D, Laboureau S, Hescot S, Julie C, Teissier MP, Thereaux J, Ferru A, Evrard C, Mathonnet M, Christou N; And the GTE Group. Mekkan-Bouv Hez M, et al. Among authors: goichot b. Int J Surg. 2024 Apr 3. doi: 10.1097/JS9.0000000000001382. Online ahead of print. Int J Surg. 2024. PMID: 38573078
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial.
Baudin E, Goichot B, Berruti A, Hadoux J, Moalla S, Laboureau S, Nölting S, de la Fouchardière C, Kienitz T, Deutschbein T, Zovato S, Amar L, Haissaguerre M, Timmers H, Niccoli P, Faggiano A, Angokai M, Lamartina L, Luca F, Cosentini D, Hahner S, Beuschlein F, Attard M, Texier M, Fassnacht M; ENDOCAN-COMETE; ENSAT Networks. Baudin E, et al. Among authors: goichot b. Lancet. 2024 Mar 16;403(10431):1061-1070. doi: 10.1016/S0140-6736(23)02554-0. Epub 2024 Feb 22. Lancet. 2024. PMID: 38402886 Clinical Trial.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network.
De Rycke O, Perrier M, Ouvrard É, Mennetrey C, Lachachi C, Bando-Delaunay A, Morland D, Goichot B, Taieb D, Walter T, Cadiot G, Cros J, Hentic O, Ruszniewski P, Lebtahi R, Imperiale A, de Mestier L. De Rycke O, et al. Among authors: goichot b. J Nucl Med. 2023 Nov;64(11):1699-1705. doi: 10.2967/jnumed.123.265584. Epub 2023 Aug 31. J Nucl Med. 2023. PMID: 37652547
233 results